Old and New Challenges in Uveitis Associated with Behçet's Disease

Area of Science:

• Ophthalmology, Rheumatology, Immunology

Background:

• Behçet's disease (BD) is a systemic vasculitis affecting young individuals, often causing severe ocular inflammation and vision loss.
• Ocular involvement in BD, particularly retinal vasculitis, can lead to rapid and irreversible vision impairment.
• Current diagnostic challenges for BD, lacking reliable biomarkers, delay early therapeutic intervention.

Purpose of the Study:

• To review recent advancements in the clinical evaluation, diagnostic investigations, and therapeutic strategies for Behçet's disease-associated uveitis.
• To highlight how innovations improve the management and visual prognosis for patients with Behçet's disease and ocular inflammation.

Main Methods:

• Literature review of recent studies on Behçet's disease, uveitis, and treatment innovations.
• Analysis of clinical evaluation techniques, diagnostic criteria, and emerging therapeutic options, including biologics.
• Focus on advancements impacting the prognosis of ocular manifestations in BD.

Main Results:

• Biologics have significantly improved intraocular inflammation management in BD.
• Despite advances, diagnosing BD remains challenging, often delaying crucial early treatment.
• Innovations in evaluation and treatment offer improved visual outcomes and reduced structural damage.

Conclusions:

• Early diagnosis and prompt treatment are critical for managing Behçet's disease and preserving vision.
• Advancements in clinical assessment and novel therapies, particularly biologics, are enhancing the prognosis for uveitis in BD.
• Continued research into reliable biomarkers and diagnostic tools is essential for timely BD management.